Dr. Roach: PCSK9i Drugs as Viable Statin Alternatives
Dr. Roach discusses the effectiveness of PCSK9 inhibitors as alternatives to statins for cholesterol management, especially in those who cannot tolerate statins, and provides insights on treatments for long-term COVID-19 related loss of smell and prurigo nodularis, emphasizing various therapeutic options.